Search Results - "Raungaard, B"

The Impact of Lipoprotein-Associated Oxidative Stress on Cell-Specific Microvesicle Release in Patients with Familial Hypercholesterolemia by Beck-Nielsen, H., Raungaard, B., Vedel, S., Irvine, H., Nielsen, M. H., Handberg, A.

“…Objective. Microvesicles (MVs) are small cell-derived particles shed upon activation. Familial hypercholesterolemia (FH) particularly when associated with…”
Get full text

Diabetes is not a risk factor for myocardial infarction in patients without coronary artery disease by Gyldenkerne, C, Olesen, K.K.W, Thrane, P.G, Madsen, M, Thim, T, Wurtz, M, Jensen, L.O, Raungaard, B, Poulsen, P.L, Boetker, H.E, Maeng, M

“…Abstract Background Diabetes is considered a risk factor for myocardial infarction (MI). However, we have previously found that diabetes was not a short-term…”
Get full text

P6464Association between anti-diabetic treatment strategy and cardiovascular risk in diabetic patients with and without coronary artery disease by Olesen, K.K.W., Madsen, M., Egholm, G., Thim, T., Jensen, L.O., Raungaard, B., Boetker, H.E., Soerensen, H.T., Maeng, M.

Get full text

LDL-receptor gene mutations and the hypocholesterolemic response to statin therapy by Brorholt-Petersen, JU, Jensen, HK, Raungaard, B, Gregersen, N, Faergeman, O

“…Studies of the cholesterol lowering effect of statin therapy as a function of low‐density lipoprotein (LDL)‐receptor mutation type have not produced a clear…”
Get full text

P1376Landmark analysis of clinical outcome following first-generation vs newer-generation coronary drug-eluting stent implantation: a pooled analysis of SORT OUT III-V studies by Maeng, M., Christiansen, E.H., Raungaard, B., Kristensen, S.D., Terkelsen, C.J., Jensen, S.E., Ravkilde, J., Junker, A., Veien, K.T., Madsen, M., Boetker, H.E., Jensen, L.O.

Get full text

31245-year clinical outcome following first-generation vs newer-generation coronary drug-eluting stent implantation: A pooled analysis of SORT OUT III, IV, and V studies by Maeng, M., Christiansen, E.H., Raungaard, B., Kristensen, S.D., Terkelsen, C.J., Jensen, S.E., Ravkilde, J., Junker, A., Veien, K.T., Madsen, M., Boetker, H.E., Jensen, L.O.

Get full text

2199Rate of very late stent thrombosis differs between drug-eluting stents: a 5-year pooled landmark analysis of the SORT OUT III, IV, and V trials by Maeng, M., Christiansen, E.H., Raungaard, B., Kristensen, S.D., Terkelsen, C.J., Jensen, S.E., Ravkilde, J., Junker, A., Veien, K.T., Madsen, M., Boetker, H.E., Jensen, L.O.

Get full text

6152A novel model for prediction of ischemic stroke in patients without atrial fibrillation by Steensig, K, Olesen, K K W, Madsen, M, Thim, T, Jensen, L O, Raungaard, B, Kristensen, S D, Boetker, H E, Lip, G Y H, Eikelboom, J W, Maeng, M

Get full text

Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus by Gyldenkerne, Christine, Olesen, Kevin Kris Warnakula, Madsen, Morten, Thim, Troels, Jensen, Lisette Okkels, Raungaard, Bent, Sørensen, Henrik Toft, Bøtker, Hans Erik, Maeng, Michael

“…We examined risk of myocardial infarction and all-cause death associated with the extent of coronary artery disease ascertained by coronary angiography in…”
Get full text

Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey by Valgimigli, Marco, Costa, Francesco, Byrne, Robert, Haude, Michael, Baumbach, Andreas, Windecker, Stephan

“…Our aim was to report on a survey initiated by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) concerning opinion on the evidence…”
Get full text

Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus [Response to Letter] by Olesen, Kevin Kris Warnakula, Gyldenkerne, Christine, Madsen, Morten, Thim, Troels, Jensen, Lisette Okkels, Raungaard, Bent, Sørensen, Henrik Toft, Bøtker, Hans Erik, Maeng, Michael

“…Kevin Kris Warnakula Olesen,1,2 Christine Gyldenkerne,1 Morten Madsen,2 Troels Thim,1 Lisette Okkels Jensen,3 Bent Raungaard,4 Henrik Toft Sørensen,2 Hans Erik…”
Get full text

Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: results of an EAPCI survey by Adamo, Marianna, Byrne, Robert A, Baumbach, Andreas, Haude, Michael, Windecker, Stephan, Valgimigli, Marco

“…Our aim was to report on a survey initiated by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) collecting the opinion of the…”
Get full text

Percutaneous removal of an in-situ embolised catheter fragment in a patient with Port-A-Cath by Raungaard, B, Thuesen, L

“…The totally implantable catheter system has gained popularity as venous access when prolonged treatment is needed. It has several advantages over other methods…”
Get more information

Same extent of coronary calcification in heterozygous familial hypercholesterolemia caused by a receptor defective and a receptor negative mutation in Danish patients by Brorholt-Petersen, J.U., Christiansen, T., Jensen, H.K., Jensen, J.M., Raungaard, B., Gregersen, N., Faergeman, O.

Get full text

Low density lipoprotein ligand function in patients with mutant apolipoprotein B-100 assessed by two-color fluorescence flow cytometry by Raungaard, B., Heath, F., Brorholt-Petersen, J.U., Jensen, H.K., Faergeman, O.

Get full text

4.P.309 Functional characterization of low density lipoprotein receptor gene mutations in patients with familial hypercholesterolemia by Raungaard, B., Heath, F., Brorholt-Petersen, J.U., Jensen, H.K., Faergeman, O.

Get full text

Colesevelam hydrochloride. A product description by Raungaard, Bent, Larsen, Mogens Lytken

Get more information

Flow Cytometric Assessment of LDL Ligand Function for Detection of Heterozygous Familial Defective Apolipoprotein B-100 by Raungaard, Bent, Heath, Finn, Hansen, Peter Steen, Brorholt-Petersen, Jens Uffe, Jensen, Henrik Kjarulf, Fargeman, Ole

“…Familial defective apolipoprotein (apo) B-100 (FDB) is caused by a mutation in the apoB gene and characterized by decreased binding of LDL to LDL receptors…”
Get full text

Flow cytometry with a monoclonal antibody to the low density lipoprotein receptor compared with gene mutation detection in diagnosis of heterozygous familial hypercholesterolemia by Raungaard, Bent, Heath, Finn, Brorholt-Petersen, Jens Uffe, Jensen, Henrik Kjarulf, Faergeman, Ole

“…We used a fluorescence flow cytometry assay with a monoclonal low density lipoprotein (LDL) receptor-specific antibody to detect LDL receptor expression on…”
Get full text

Flow Cytometric Assessment of Effects of Fluvastatin on Low-Density Lipoprotein Receptor Activity in Stimulated T-Lymphocytes from Patients with Heterozygous Familial Hypercholesterolemia by Raungaard, Bent, Brorholt-Petersen, Jens Uffe, Jensen, Henrik Kjærulf, Færgeman, Ole

“…To test the effects of fluvastatin on low‐density lipoprotein (LDL) receptor activity in patients with heterozygous familial hypercholesterolemia, the authors…”
Get full text